Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pharmacogenetics & Genomics

• Publication date

  2010-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/FPC.0b013e3283349eb0PMID 20010382PMCID PMC2883163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bile Secretion and the Enterohepatic Circulation

  2010cited by this paper
• Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre‐messenger RNA splicing

  2009cited by this paper
• Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.

  2008cited by this paper
• Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.

  2008cited by this paper
• Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

  2007cited by this paper
• Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.

  2007cited by this paper
• Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury

  2007cited by this paper
• Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.

  2006cited by this paper
• Genetic Variability, Haplotype Structures, and Ethnic Diversity of Hepatic Transporters MDR3 (ABCB4) and Bile Salt Export Pump (ABCB11)

  2006cited by this paper
• Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump.

  2006cited by this paper
• Interindividual variability of canalicular ATP‐binding‐cassette (ABC)–transporter expression in human liver

  2006influential reference
• Bile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin

  2005cited by this paper
• Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11

  2005cited by this paper
• Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.

  2005cited by this paper
• Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11.

  2004cited by this paper
• A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump.

  2004cited by this paper
• Ethnicity-dependent Polymorphism in Na+-taurocholate Cotransporting Polypeptide (SLC10A1) Reveals a Domain Critical for Bile Acid Substrate Recognition*

  2004cited by this paper
• Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy.

  2003cited by this paper
• Bile salt transporters: molecular characterization, function, and regulation.

  2003cited by this paper
• Natural variation in human membrane transporter genes reveals evolutionary and functional constraints

  2003cited by this paper
• SNP genotyping by the 5'-nuclease reaction.

  2003cited by this paper
• SNP Genotyping by the ′’-Nuclease Reaction

  2003cited by this paper
• Functional expression of the canalicular bile salt export pump of human liver.

  2002cited by this paper
• The human bile salt export pump: characterization of substrate specificity and identification of inhibitors.

  2002cited by this paper
• The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.

  2002cited by this paper
• The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions

  2001cited by this paper
• BSEP: Function and Role in Progressive Familial Intrahepatic Cholestasis

  2001cited by this paper
• Bile salt export pump is highly conserved during vertebrate evolution and its expression is inhibited by PFIC type II mutations.

  2001cited by this paper
• Transport of bile acids in hepatic and non-hepatic tissues.

  2001cited by this paper
• Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.

  2001cited by this paper
• Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.

  2000cited by this paper
• Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein.

  2000cited by this paper
• Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.

  1999cited by this paper
• Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.

  1999cited by this paper
• A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis

  1998cited by this paper
• The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver*

  1998influential reference
• Identification of a sister gene to P-glycoprotein.

  1995cited by this paper
• Histologic Pathology of the Liver in Progressive Familial Intrahepatic Cholestasis

  1994cited by this paper
• Clinical and Biochemical Findings in Progressive Familial Intrahepatic Cholestasis

  1994cited by this paper
• Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters.

  1991cited by this paper
• Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system.

  1991cited by this paper

• Case Report: Genetic predisposition to low-dose NSAID-induced liver injury in real-world China

  2025cites this paper
• In Vitro-In Silico Models to Elucidate Mechanisms of Bile Acid Disposition and Cellular Aerobics in Human Hepatocytes

  2025cites this paper
• Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis

  2023cites this paper
• Pharmacogenomic mechanisms of drug toxicity

  2022cites this paper
• Pharmacogenomic landscape of Indian population using whole genomes

  2022cites this paper
• Rare variant contribution to cholestatic liver disease in a South Asian population in the United Kingdom

  2022cites this paper
• The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies

  2021cites this paper
• Mechanism‐Based Experimental Models for the Evaluation of BSEP Inhibition and DILI

  2021cites this paper
• Structure and Function of Hepatobiliary ATP Binding Cassette Transporters.

  2020cites this paper
• The Role of the Sodium-taurocholate Co-transporting Polypeptide (NTCP) and Bile Salt Export Pump (BSEP) in Related Liver Disease.

  2019cites this paper
• Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.

  2019cites this paper
• Familial intrahepatic cholestasis: New and wide perspectives.

  2019cites this paper
• Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment.

  2018cites this paper
• Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective

  2018cites this paper
• Computational analysis of genomic variants affecting predicted microRNA:target interactions in prostate cancer.

  2018cites this paper
• Tacrolimus Concentration in Saliva of Kidney Transplant Recipients: Factors Influencing the Relationship with Whole Blood Concentrations

  2018cites this paper
• Bile Salt Export Pump: Drug-Induced Liver Injury and Assessment Approaches

  2018cites this paper
• Predicting drug-induced cholestasis: preclinical models

  2018cites this paper
• Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems.

  2018cites this paper
• Hepatobiliary Transport of Bile Acids

  2017cites this paper
• Bile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of Troglitazone

  2017cites this paper
• A Complex Case of Cholestasis in a Patient with ABCB4 and ABCB11 Mutations

  2017cites this paper
• Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats.

  2016influential citation
• Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function

  2016cites this paper
• Effect of common polymorphisms of the farnesoid X receptor and bile acid transporters on the pharmacokinetics of ursodeoxycholic acid

  2016cites this paper
• Two Liver Transporters, ABCB11 and ABCC6; Novel Therapeutic Approaches in the Related Disorders

  2016cites this paper
• Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort

  2016cites this paper
• In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.

  2016cites this paper
• In silico investigation of the impact of synonymous variants in ABCB4 gene on mRNA stability/structure, splicing accuracy and codon usage: Potential contribution to PFIC3 disease

  2016cites this paper
• Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment

  2016cites this paper
• Transporters in the Liver

  2015cites this paper
• Variations of ABCB4 and ABCB11 genes are associated with primary intrahepatic stones.

  2015cites this paper
• Quantification of Drug-Induced Inhibition of Canalicular Cholyl-l-Lysyl-Fluorescein Excretion From Hepatocytes by High Content Cell Imaging.

  2015cites this paper
• No Contribution of the ABCB11 p.444A Polymorphism in Japanese Patients with Drug-Induced Cholestasis

  2015cites this paper
• Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.

  2014cites this paper
• Genetic variations of bile salt transporters.

  2014cites this paper
• Clinical application of transcriptional activators of bile salt transporters☆

  2014cites this paper
• The Role of Organic Anion Transporters in Diagnosing Liver Diseases by Magnetic Resonance Imaging

  2014cites this paper
• Beyond the ITC White Paper: emerging sciences in drug transporters and opportunities for drug development.

  2014cites this paper
• Association of CYP2C9*2 With Bosentan‐Induced Liver Injury

  2013cites this paper
• Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions.

  2013cites this paper
• Role of Membrane Transport in Hepatotoxicity and Pathogenesis of Drug-Induced Cholestasis

  2013cites this paper
• Association of variants of ABCB11 with transient neonatal cholestasis

  2013cites this paper
• Bile formation and secretion.

  2013cites this paper
• Clinical variability of mutations in the ABCB11 gene: a case report.

  2013cites this paper
• Strategies for Minimisation of the Cholestatic Liver Injury Liability Posed by Drug- Induced Bile Salt Export Pump (BSEP) Inhibition

  2013cites this paper
• The bile salt export pump (BSEP/ABCB11)

  2013cites this paper
• The Pharmacogenomics of Membrane Transporters Project

  2013cites this paper
• Solute Carrier (SLC) Family Transporters

  2012cites this paper
• The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury

  2012cites this paper
• The bile salt export pump (BSEP) in health and disease.

  2012cites this paper
• Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics

  2012cites this paper
• In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans

  2012cites this paper
• A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population

  2012cites this paper
• Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development

  2012influential citation
• Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family.

  2011cites this paper
• Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis

  2011cites this paper
• Scoparone potentiates transactivation of the bile salt export pump gene and this effect is enhanced by cytochrome P450 metabolism but abolished by a PKC inhibitor

  2011cites this paper
• Effects of gender, and SLCO1B1 and CYP7A1 polymorphisms on plasma bile acids in humans and the pharmacokinetics of therapeutic ursodeoxycholic acid

  2011cites this paper
• Molecular mechanisms of drug transporter regulation.

  2011cites this paper
• Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice.

  2011cites this paper
• An Update on Genetic Analysis of Cholestatic Liver Diseases: Digging Deeper

  2011cites this paper
• Genetic Determinants of Drug-induced Cholestasis and Intrahepatic Cholestasis of Pregnancy

  2010cites this paper
• Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.

  2010cites this paper
• The Bile Salt Export Pump: Clinical and Experimental Aspects of Genetic and Acquired Cholestatic Liver Disease

  2010cites this paper